Published in Virus Evol on February 14, 2016
The Protein Data Bank. Nucleic Acids Res (2000) 187.10
MUSCLE: multiple sequence alignment with high accuracy and high throughput. Nucleic Acids Res (2004) 168.89
Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res (2003) 103.76
A simple, fast, and accurate algorithm to estimate large phylogenies by maximum likelihood. Syst Biol (2003) 102.57
Overview of the CCP4 suite and current developments. Acta Crystallogr D Biol Crystallogr (2011) 67.55
PAML 4: phylogenetic analysis by maximum likelihood. Mol Biol Evol (2007) 45.68
jModelTest: phylogenetic model averaging. Mol Biol Evol (2008) 44.78
The rapid generation of mutation data matrices from protein sequences. Comput Appl Biosci (1992) 44.38
The interpretation of protein structures: estimation of static accessibility. J Mol Biol (1971) 40.24
Evolution and ecology of influenza A viruses. Microbiol Rev (1992) 39.99
Protein structure prediction on the Web: a case study using the Phyre server. Nat Protoc (2009) 32.64
Antigenic and genetic characteristics of swine-origin 2009 A(H1N1) influenza viruses circulating in humans. Science (2009) 25.61
HyPhy: hypothesis testing using phylogenies. Bioinformatics (2004) 17.33
Structural identification of the antibody-binding sites of Hong Kong influenza haemagglutinin and their involvement in antigenic variation. Nature (1981) 15.85
FastTree: computing large minimum evolution trees with profiles instead of a distance matrix. Mol Biol Evol (2009) 15.15
Mapping the antigenic and genetic evolution of influenza virus. Science (2004) 14.28
The structure and function of the hemagglutinin membrane glycoprotein of influenza virus. Annu Rev Biochem (1987) 11.99
The influenza virus resource at the National Center for Biotechnology Information. J Virol (2007) 11.33
Likelihood models for detecting positively selected amino acid sites and applications to the HIV-1 envelope gene. Genetics (1998) 11.25
The annual impact of seasonal influenza in the US: measuring disease burden and costs. Vaccine (2007) 9.96
ProtTest 3: fast selection of best-fit models of protein evolution. Bioinformatics (2011) 8.68
Codon-substitution models for detecting molecular adaptation at individual sites along specific lineages. Mol Biol Evol (2002) 7.21
The nature of the accessible and buried surfaces in proteins. J Mol Biol (1976) 5.92
Long term trends in the evolution of H(3) HA1 human influenza type A. Proc Natl Acad Sci U S A (1997) 5.76
STUDIES OF ANTIGENIC DIFFERENCES AMONG STRAINS OF INFLUENZA A BY MEANS OF RED CELL AGGLUTINATION. J Exp Med (1943) 5.67
Structural basis of immune recognition of influenza virus hemagglutinin. Annu Rev Immunol (1990) 5.37
Positive selection on the H3 hemagglutinin gene of human influenza virus A. Mol Biol Evol (1999) 4.97
Comparison of complete amino acid sequences and receptor-binding properties among 13 serotypes of hemagglutinins of influenza A viruses. Virology (1991) 4.85
New world bats harbor diverse influenza A viruses. PLoS Pathog (2013) 4.10
Hemagglutinin receptor binding avidity drives influenza A virus antigenic drift. Science (2009) 3.88
Detecting individual sites subject to episodic diversifying selection. PLoS Genet (2012) 3.77
An overlapping protein-coding region in influenza A virus segment 3 modulates the host response. Science (2012) 3.70
A method for detecting positive selection at single amino acid sites. Mol Biol Evol (1999) 3.58
Substitutions near the receptor binding site determine major antigenic change during influenza virus evolution. Science (2013) 3.38
Continuous and discontinuous protein antigenic determinants. Nature (1986) 3.26
Influenza A viruses: new research developments. Nat Rev Microbiol (2011) 3.00
A complicated message: Identification of a novel PB1-related protein translated from influenza A virus segment 2 mRNA. J Virol (2009) 2.94
A random effects branch-site model for detecting episodic diversifying selection. Mol Biol Evol (2011) 2.88
Maximum likelihood estimation on large phylogenies and analysis of adaptive evolution in human influenza virus A. J Mol Evol (2000) 2.78
Broadly neutralizing hemagglutinin stalk-specific antibodies require FcγR interactions for protection against influenza virus in vivo. Nat Med (2014) 2.72
Simultaneous amino acid substitutions at antigenic sites drive influenza A hemagglutinin evolution. Proc Natl Acad Sci U S A (2007) 2.67
Selectionism and neutralism in molecular evolution. Mol Biol Evol (2005) 2.64
Influenza vaccine strain selection and recent studies on the global migration of seasonal influenza viruses. Vaccine (2008) 2.56
Prevalence of epistasis in the evolution of influenza A surface proteins. PLoS Genet (2011) 2.41
Structures of influenza A proteins and insights into antiviral drug targets. Nat Struct Mol Biol (2010) 2.31
Evolution of the receptor binding properties of the influenza A(H3N2) hemagglutinin. Proc Natl Acad Sci U S A (2012) 2.18
Influenza vaccine immunology. Immunol Rev (2011) 2.02
A maximum likelihood method for detecting directional evolution in protein sequences and its application to influenza A virus. Mol Biol Evol (2008) 1.96
Reliabilities of identifying positive selection by the branch-site and the site-prediction methods. Proc Natl Acad Sci U S A (2009) 1.94
Two residues in the hemagglutinin of A/Fujian/411/02-like influenza viruses are responsible for antigenic drift from A/Panama/2007/99. Virology (2005) 1.91
Low 2012-13 influenza vaccine effectiveness associated with mutation in the egg-adapted H3N2 vaccine strain not antigenic drift in circulating viruses. PLoS One (2014) 1.90
Statistical properties of the branch-site test of positive selection. Mol Biol Evol (2010) 1.85
Integrating influenza antigenic dynamics with molecular evolution. Elife (2014) 1.80
The geometry of shape space: application to influenza. J Theor Biol (2001) 1.59
Epitope mapping: the first step in developing epitope-based vaccines. BioDrugs (2007) 1.58
Identification of a novel splice variant form of the influenza A virus M2 ion channel with an antigenically distinct ectodomain. PLoS Pathog (2012) 1.55
The genomic rate of molecular adaptation of the human influenza A virus. Mol Biol Evol (2011) 1.48
Bioinformatics models for predicting antigenic variants of influenza A/H3N2 virus. Bioinformatics (2008) 1.47
Natural selection on the influenza virus genome. Mol Biol Evol (2006) 1.47
The role of genomics in tracking the evolution of influenza A virus. PLoS Pathog (2009) 1.39
CED: a conformational epitope database. BMC Immunol (2006) 1.39
Potential antigenic explanation for atypical H1N1 infections among middle-aged adults during the 2013-2014 influenza season. Proc Natl Acad Sci U S A (2014) 1.37
Broadly neutralizing antibodies against influenza viruses. Antiviral Res (2013) 1.29
Recommended composition of influenza virus vaccines for use in the 2014-2015 northern hemisphere influenza season. Wkly Epidemiol Rec (2014) 1.26
Discordant antigenic drift of neuraminidase and hemagglutinin in H1N1 and H3N2 influenza viruses. Proc Natl Acad Sci U S A (2011) 1.23
New methods for detecting positive selection at single amino acid sites. J Mol Evol (2004) 1.21
Maximum allowed solvent accessibilites of residues in proteins. PLoS One (2013) 1.18
Identifying potential immunodominant positions and predicting antigenic variants of influenza A/H3N2 viruses. Vaccine (2007) 1.16
Integrating sequence variation and protein structure to identify sites under selection. Mol Biol Evol (2012) 1.15
Antigenic drift in H5N1 avian influenza virus in poultry is driven by mutations in major antigenic sites of the hemagglutinin molecule analogous to those for human influenza virus. J Virol (2011) 1.14
Co-evolution positions and rules for antigenic variants of human influenza A/H3N2 viruses. BMC Bioinformatics (2009) 1.13
Using sequence data to infer the antigenicity of influenza virus. MBio (2013) 1.10
Recommended composition of influenza virus vaccines for use in the 2005-2006 influenza season. Wkly Epidemiol Rec (2005) 1.09
Allele dynamics plots for the study of evolutionary dynamics in viral populations. Nucleic Acids Res (2010) 1.08
Single hemagglutinin mutations that alter both antigenicity and receptor binding avidity influence influenza virus antigenic clustering. J Virol (2013) 1.04
Recommended composition of influenza virus vaccines for use in the 2013–2014 northern hemisphere influenza season. Wkly Epidemiol Rec (2013) 1.01
Recommended composition of influenza virus vaccines for use in the 2009 southern hemisphere influenza season. Wkly Epidemiol Rec (2008) 1.00
Detecting patches of protein sites of influenza A viruses under positive selection. Mol Biol Evol (2012) 0.95
Recommended composition of influenza virus vaccines for use in the 2008-2009 influenza season. Wkly Epidemiol Rec (2008) 0.94
An overview of influenza haemagglutinin and neuraminidase. Biologicals (2009) 0.94
Recommended composition of influenza virus vaccines for use in the 2009-2010 influenza season (northern hemisphere winter). Wkly Epidemiol Rec (2009) 0.92
Recommended composition of influenza virus vaccines for use in the 2007-2008 influenza season. Wkly Epidemiol Rec (2007) 0.92
Geometric Constraints Dominate the Antigenic Evolution of Influenza H3N2 Hemagglutinin. PLoS Pathog (2015) 0.92
Changed epitopes drive the antigenic drift for influenza A (H3N2) viruses. BMC Bioinformatics (2011) 0.88
Analysis of antigenically important residues in human influenza A virus in terms of B-cell epitopes. J Virol (2011) 0.84
Recommended composition of influenza virus vaccines for use in the 2008 influenza season. Wkly Epidemiol Rec (2007) 0.83
Inference of genotype-phenotype relationships in the antigenic evolution of human influenza A (H3N2) viruses. PLoS Comput Biol (2012) 0.82
Recommended composition of influenza virus vaccines for use in the 2007 influenza season. Wkly Epidemiol Rec (2006) 0.81
Recommended composition of influenza virus vaccines for use in the 2006 influenza season. Wkly Epidemiol Rec (2005) 0.79
Improved high-throughput virus neutralisation assay for antibody estimation against pandemic and seasonal influenza strains from 2009 to 2011. J Virol Methods (2013) 0.76
Monitoring the antigenic evolution of human influenza A viruses to understand how and when viruses escape from existing immunity. BMC Res Notes (2013) 0.76